Robert Huizinga|Therese Voyer

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Robert Huizinga

Therese Voyer

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

CANNT Journal = Journal ACITN|November 5, 2003

New paradigms in immunosuppressionRobert Huizinga, Therese Voyer

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|August 8, 2002

Update in immunosuppressionRobert Huizinga

Journal of the American Academy of Dermatology|February 21, 2006

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasisRobert Bissonnette, Kim Papp, Yves Poulin, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

CANNT Journal = Journal ACITN|November 5, 2003

New paradigms in immunosuppressionRobert Huizinga, Therese Voyer

Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|August 8, 2002

Update in immunosuppressionRobert Huizinga

Journal of the American Academy of Dermatology|February 21, 2006

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasisRobert Bissonnette, Kim Papp, Yves Poulin, et al.

Pageof 1